Evidence map›Paper›PMID 19074144›Full record

ArticleThe Journal of biological chemistry2009

The Mycobacterium tuberculosis beta-ketoacyl-acyl carrier protein synthase III activity is inhibited by phosphorylation on a single threonine residue.

Romain Veyron-Churlet, Virginie Molle, Rebecca C Taylor, Alistair K Brown, Gurdyal S Besra, Isabelle Zanella-Cléon, Klaus Fütterer, Laurent Kremer

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 72 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Structure of theCurrent research in structural biology · 2021
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Romain Veyron-ChurletLaboratoire de Dynamique des Interactions Membranaires Normales et Pathologiques, Universités de Montpellier II et I, CNRS UMR 5235, INSERM, Place Eugène Bataillon, 34095 Montpellier Cedex 05, France.
Virginie Molle
Rebecca C Taylor
Alistair K Brown
Gurdyal S Besra
Isabelle Zanella-Cléon
Klaus Fütterer
Laurent Kremer
University of Birmingham · GBCentre National de la Recherche Scientifique · FRUniversité Claude Bernard Lyon 1 · FR

Funding

Medical Research Council G0500590
6 · The paper itself

Abstract

Mycolic acids are hallmark features of the Mycobacterium tuberculosis cell wall. They are synthesized by the condensation of two fatty acids, a C56-64-meromycolyl chain and a C24-26-fatty acyl chain. Meromycolates are produced via the combination of type I and type II fatty acid synthases (FAS-I and FAS-II). The beta-ketoacyl-acyl carrier protein (ACP) synthase III (mtFabH) links FAS-I and FAS-II, catalyzing the condensation of FAS-I-derived acyl-CoAs with malonyl-ACP. Because mtFabH represents a potential regulatory key point of the mycolic acid pathway, we investigated the hypothesis that phosphorylation of mtFabH controls its activity. Phosphorylation of proteins by Ser/Thr protein kinases (STPKs) has recently emerged as a major physiological mechanism of regulation in prokaryotes. We demonstrate here that mtFabH was efficiently phosphorylated in vitro by several mycobacterial STPKs, particularly by PknF and PknA, as well as in vivo in mycobacteria. Analysis of the phosphoamino acid content indicated that mtFabH was phosphorylated exclusively on threonine residues. Mass spectrometry analyses using liquid chromatography-electrospray ionization/tandem mass spectrometry identified Thr45 as the unique phosphoacceptor. This was further supported by complete loss of PknF- or PknA-dependent phosphorylation of a mtFabH mutant. Mapping Thr45 on the crystal structure of mtFabH illustrates that this residue is located at the entrance of the substrate channel, suggesting that the phosphate group may alter accessibility of the substrate and thus affect mtFabH enzymatic activity. A T45D mutant of mtFabH, designed to mimic constitutive phosphorylation, exhibited markedly decreased transacylation, malonyl-AcpM decarboxylation, and condensing activities compared with the wild-type protein or the T45A mutant. Together, these findings not only represent the first demonstration of phosphorylation of a beta-ketoacyl-ACP synthase III enzyme but also indicate that phosphorylation of mtFabH inhibits its enzymatic activity, which may have important consequences in regulating mycolic acid biosynthesis.

Indexed as

3-Oxoacyl-(Acyl-Carrier-Protein) SynthaseAcyl Carrier ProteinAmino Acid SubstitutionBacterial ProteinsCrystallography, X-RayFatty Acid SynthasesFatty Acid Synthase, Type IIMutationMycobacterium tuberculosisMycolic AcidsPeptide MappingPhosphorylationProtein Serine-Threonine KinasesThreonine3-ketoacyl-acyl carrier protein synthase III3-Oxoacyl-(Acyl-Carrier-Protein) SynthaseAcyl Carrier ProteinBacterial ProteinsFabH protein, Mycobacterium tuberculosisfatty acid synthase I, mycobacteriaFatty Acid SynthasesFatty Acid Synthase, Type IImeromycolic acidsMycolic AcidsPknA protein, Mycobacterium tuberculosisPknF protein, Mycobacterium tuberculosisProtein Serine-Threonine KinasesThreonine

Identifiers

PMID19074144
PMCPMC2649087
OpenAlexW2064530175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.